123.06USD+2.00%Mkt Cap: —P/E: 20.091d ago
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and servi…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap—
Enterprise Value16.14B $
Revenue (TTM)2.91B $
Gross Profit1.60B $
Net Income (TTM)237.37M $
Revenue/Share25.77 USD
Last Price123.06 USD
Fiscal Year EndDec 2025
MR QuarterJul 2026
Employees11.0K
CountryGB
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)20.09
P/E (Forward)—
PEG—
EV/EBITDA18.42
EV/Revenue5.54
P/S—
P/B1.91
EPS (TTM)6.16
EPS (Forward)—
52W Range
113.4496% of range123.44
52W High123.44 USD
52W Low113.44 USD
Profitability
Gross Margin54.98%
Oper. Margin17.05%
EBITDA Margin30.08%
Profit Margin8.16%
ROE3.21%
ROA2.37%
Growth
Revenue Growth1.30%
Earnings Growth1.20%
Cash Flow & Leverage
Operating CF627.63M $
CapEx (TTM)—
FCF Margin20.78%
FCF Yield—
Net Debt2.32B $
Net Debt/EBITDA2.65
Balance Sheet
Debt/Equity46.23
Current Ratio1.80
Quick Ratio1.36
Book Value/Sh64.78 USD
Cash/Share9.167 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.2800 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.111.24M
Float102.48M
Insiders0.27%
Institutions103.60%
Technical
SMA 50107.07 (+14.9%)
SMA 200110.50 (+11.4%)
Beta1.07
S&P 52W Chg18.16%
Avg Vol (30d)285
Avg Vol (10d)62
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—